CD274 and cancer: However, little is known about predictive factors of efficacy of such therapies, although some recent reports described that across multiple cancer types, responses are observed in patients with tumors expressing high levels of PD-L1, especially when PD-L1 was expressed by tumor-infiltrating immune cells.